In particular, it has been shown that inosine reduced 3-nitropropionic acid (3-NP)-induced HD-like symptoms in rats, at least in part, by activating the A2AR/BDNF/TrKB/ERK/CREB signaling pathway [74]. Here, CREB1 is linked to Huntington disease.